Navigation Links
Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)
Date:9/3/2007

REINACH, Switzerland, September 3 /PRNewswire/ -- Nitec Pharma AG, today announced the appointments of Anders Harfstrand as Chief Executive Officer, and Andrea Buscaglia as Chief Financial Officer. Both executives bring with them a wealth of strategic knowledge and expertise which complement that of the existing management team. The appointments will enable Nitec to drive the commercialization of its late-stage product, Lodotra (R) and progress the development of its pipeline.

Dr. Harfstrand and Mr. Buscaglia will complete Nitec's management team. They will work alongside the company's co-founders Jochen Mattis, Executive VP of Marketing and Sales and Dr. Achim Schaffler, Executive VP of R&D and Technical operations.

"I am extremely pleased that Anders has joined the Nitec Pharma team" said Dr. Karl Nagler, Member of Nitec's board of directors and Principal at Atlas Venture. "He has tremendous worldwide operational experience and impressive expertise in sales, marketing and business development. With Anders joining Nitec's management Board, we expect continued strong performance from Nitec going forward."

Dr. Harfstrand added, "I look forward to working with Nitec's experienced team to make Lodotra (R) a great success in treating rheumatoid arthritis. We intend to establish Nitec as a reliable partner for patients, physicians and investors by developing leading products and delivering innovative and cost-effective solutions for chronic inflammatory diseases and pain."

Commenting on Mr. Buscaglia's appointment, Jochen Mattis stated, "Andrea will be a great asset to our management team. During his career, he has been involved in numerous financial transactions, including several IPOs, giving him the experience to give strategic input and direction to our business. We are convinced that Andrea`s expertise will support Nitec during this exciting phase in the company's development."

Dr. Harfstrand brings to Nitec Pharma almost 20 year
'/>"/>

SOURCE Nitec Pharma AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Promega and Benitec settle contract case
2. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
3. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
4. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
5. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
6. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
7. Germantown drug company hires pharma veteran James Davidson as COO
8. Deltanoid Pharmaceuticals begins phase II osteoporosis study
9. New angel capital centered on GenTel agreement with big pharma
10. The deconstruction of Big Pharma
11. Big pharma seeks Wisconsin biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 GlassesOff ... image processing functions in the human vision system, announced today ... point guard Chris Paul to develop a ... who want to improve their real-life on-court performance. ... court, whether it is shooting a ball or blocking a ...
(Date:8/27/2015)... ... August 27, 2015 , ... METTLER TOLEDO's web-based ... the product choices to a manageable shortlist of bench and floor scales and ... that fit best with the customer’s industry and application. , Side-by-side product ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... recently presented new data on the relationship of genetics and hypertension at the ... on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an ...
(Date:8/26/2015)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended June 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... our Oral Amp B program, rapidly advancing towards ... Andrew Rae , President & CEO of iCo ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3METTLER TOLEDO Updates Online Scale Selection Tool 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3
... Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer ... CT Laser,Mammography (CTLM(R)) system, designed as an adjunct to ... applications were featured in,a cover story in the September ... was contributed by Eric Milne, MD, FRCR, FRCP, IMDS ...
... (Nasdaq: HALO ), a biopharmaceutical company developing ... announced,that its Board of Directors amended the Rights ... Agreement") in order to increase the ownership,threshold for ... Agreement from a fifteen percent (15%) ownership interest ...
... EDMONTON, Nov. 14 /PRNewswire-FirstCall/ - BioMS Medical Corp ... multiple sclerosis (MS), today,announced financial and operational results ... "During the quarter, we continued to maintain momentum ... the treatment of multiple,sclerosis," said Kevin Giese, President ...
Cached Biology Technology:New Optical Breast Cancer Imaging Technology Garners Cover Story in National Radiology Magazine 2New Optical Breast Cancer Imaging Technology Garners Cover Story in National Radiology Magazine 3Halozyme Therapeutics Amends Stockholder Rights Plan 2BioMS Medical announces third quarter 2007 results 2BioMS Medical announces third quarter 2007 results 3BioMS Medical announces third quarter 2007 results 4
(Date:8/5/2015)... York , August 5, 2015 ... report titled "Facial Recognition Market - Global Industry Analysis, ... the global market for facial recognition is forecast to ... driven by increased demand for surveillance systems by civil ... rising number of crimes and terrorist activities across the ...
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... de julio de 2015 BGI llevará a cabo ... del 22 al 25 de octubre de 2015, en ... conferencia celebra su décimo aniversario este año. Desde su ... de las reuniones anuales más influyentes del mundo en ... las conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... waters, nutrients must be removed in order to avoid eutrophication ... to animal and plant life. Robert Almstrand at the University ... removal of nitrogen from wastewater can be achieved by providing ... low levels of nutrients. The emission of wastewater to ...
... Many adolescents frequently expose their ears to loud sounds, ... may think that ,the doctor said that my hearing ... loud volume,. A new doctoral thesis from the University ... can be used to positively change adolescents, awareness and ...
... the University of California, Davis, have invented a superthin ... "The material itself (say, semiconductor wafers) would break ... of biomedical engineering. He and his fellow researchers have ... thick layer between two surfaces. Pan,s nanoglue, which conducts ...
Cached Biology News:New methods for better purification of wastewater 2Teaching about hearing can save young people's ears 2